Humoral Immunogenicity of Sars-Cov-2 Vaccination in the First Year after Hematopoietic Cell Transplant or Chimeric Antigen Receptor T Cell Therapy: A CIBMTR and BMT CTN Study

Riches, Marcie L.; Hill, Joshua A.; Martens, Michael, Auletta, Jeffery James, Baluch, Aliyah, Bhavsar, Kavita, Brown, Janice, Dhodapkar, Madhav Vishnu, DiFronzo, Nancy, Howard, Alan, Ibrahim, Uroosa, Nakamura, Ryotaro, Peyton, Kristin, Shahid, Zainab, Sharon, Elad, Spahn, Ashley, Toor, Amir A.; Waldvogel, Stephanie, Westervelt, Peter, Young, Jo-Anne H.; Perales, Miguel-Angel, Horowitz, Mary M.

Riches, Marcie L.; Hill, Joshua A.; Martens, Michael, Auletta, Jeffery James, Baluch, Aliyah, Bhavsar, Kavita, Brown, Janice, Dhodapkar, Madhav Vishnu, DiFronzo, Nancy, Howard, Alan, Ibrahim, Uroosa, Nakamura, Ryotaro, Peyton, Kristin, Shahid, Zainab, Sharon, Elad, Spahn, Ashley, Toor, Amir A.; Waldvogel, Stephanie, Westervelt, Peter, Young, Jo-Anne H.; Perales, Miguel-Angel, Horowitz, Mary M..

Transplantation and cellular therapy ; 28(3):S372-S373, 2022.

Article in English | EuropePMC | ID: covidwho-1749699

Search on Google

XML

Collection: Databases of international organizations Database: EuropePMC Topics: Vaccines Language: English Journal: Transplantation and cellular therapy Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML